Intellia Therapeutics, Inc.

NASDAQ:NTLA

Biotechnology

Healthcare
$9.52 +0.14%

+$0.02 today

Market cap
$1.34B
Beta
1.81
P/E (TTM)
-4.6
EPS (TTM)
-$3.33
52W Low $7.95High $28.25

Volume 9.96M

Average 6.11M

Balance Sheet

Inspect the capital base behind the business.

Assets

$842.13M

FY 2025 · Annual

-29.3% YoY

Liabilities

$170.73M

FY 2025 · Annual

-46.5% YoY

Equity

$671.39M

FY 2025 · Annual

-23.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents123.41M523.51M226.75M189.18M155.46M
Short-term Investments625.28M669.12M685.48M412.33M294.42M
Net Receivables2.03M3.77M36.46M8.52M9.47M
Inventory00000
Other Current Assets020.41M49.65M29.83M68.36M
Total Current Assets769.3M1.22B998.33M639.86M527.71M
Property, Plant & Equipment (Net)100.11M161M148.14M246.67M123.63M
Goodwill00000
Intangible Assets00000
Long-term Investments425.05M142.32M154.51M44.26M35.54M
Tax Assets00000
Other Non-current Assets000260.22M155.25M
Total Non-current Assets525.16M303.32M302.65M551.15M314.42M
Total Assets1.29B1.52B1.3B1.19B842.13M
Account Payables9.65M5.15M7.45M14.59M20.25M
Short-term Debt00000
Tax Payables00000
Deferred Revenue63.76M43.84M22.14M20.66M7.29M
Other Current Liabilities20.36M21.78M6.89M24.08M23.07M
Total Current Liabilities125.83M126.55M115.21M110.85M103.88M
Long-term Debt000066.85M
Deferred Tax Liabilities00(38.85M)00
Deferred Revenue (Non-current)63.48M19.93M38.85M18.26M0
Other Non-current Liabilities024.03M38.85M00
Total Non-current Liabilities128.39M157.98M135.6M208.21M66.85M
Total Liabilities254.22M284.53M250.81M319.06M170.73M
Common Stock7K9K9K10K12K
Retained Earnings(703M)(1.18B)(1.66B)(2.18B)(2.59B)
Accumulated OCI(2.63M)(7.46M)(2.26M)605K1.03M
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.04B1.24B1.05B871.96M671.39M
Total Debt74.02M130.7M115.35M210.2M93.33M
Net Debt(49.38M)(392.8M)(111.4M)21.02M(62.14M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$134.7M
Short-term Investments$241.3M
Receivables$9.1M
Other Current$81.3M
Total Current Assets$466.4M
PP&E (Net)$113.1M
Long-term Investments$38.0M
Other Non-current$141.3M
Total Non-current Assets$292.3M
Total Assets$758.8M

Analysis

Selected assets total $758.8M for Latest. The largest visible component is Short-term Investments at $241.3M, about 31.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-K/A8-K/A filingNov 13, 2026
8-KCurrent reportNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026

How much cash does NTLA have?

Intellia Therapeutics, Inc. (NTLA) reported $155.46M in cash and equivalents in fiscal 2025.

How much debt does NTLA carry?

Intellia Therapeutics, Inc. (NTLA) reported $93.33M of total debt, with net debt of -$62.13M.